ReviewFrontiers in medicine2022

Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment.

Gloria Delfanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.